SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System - Drug-eluting coronary artery stent, biodegradable-polymer-coated

Country: Australia

Bahasa: Inggeris

Sumber: Department of Health (Therapeutic Goods Administration)

Beli sekarang

Laporan Penilaian Awam Laporan Penilaian Awam (PAR)
09-11-2017

Boleh didapati daripada:

Boston Scientific Pty Ltd

Kelas:

Class III

Dikeluarkan oleh:

Boston Scientific Corporation 300 Boston Scientific Way, Marlborough, MA, 01752 United States Of America

Kawasan terapeutik:

58771 - Drug-eluting coronary artery stent, biodegradable-polymer-coated

Tanda-tanda terapeutik:

The SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System is mounted on a balloon expandable delivery catheter, is inserted percutaneously and advanced through the vasculature to the site of the lesion. The balloon is then inflated to expand the stent to the appropriate diameter. Finally, the balloon is deflated and the balloon catheter removed, leaving the stent in position. The SYNERGY Stent System is indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease, including patients with acute myocardial infarction, due to discrete de novo native coronary artery lesions. This device is MR conditional.

Status kebenaran:

A

Tarikh kebenaran:

2014-02-21

Cari amaran yang berkaitan dengan produk ini